Method of using small diameter intracorneal inlays to treat visual impairment

Information

  • Patent Grant
  • 8057541
  • Patent Number
    8,057,541
  • Date Filed
    Monday, October 30, 2006
    17 years ago
  • Date Issued
    Tuesday, November 15, 2011
    12 years ago
Abstract
Provided herein are small diameter inlays for correcting vision impairments by altering the shape of the anterior corneal surface. In an embodiment, inlays having diameters smaller than the pupil are provided for correcting presbyopia. To provide near vision, an inlay is implanted centrally in the cornea to induce an “effective” zone on the anterior corneal surface, within which diopter power is increased. Distance vision is provided by a region of the cornea peripheral to the “effect” zone. In another embodiment, small diameter inlays are provided that induce effective optical zones on the anterior corneal surface that are much larger in diameter than the inlays. The increase in the effective optical zone, due at least in part to a draping effect, allows an inlay to produce a much larger clinical effect on a patient's vision than the diameter of the inlay.
Description
FIELD OF THE INVENTION

The field of the invention relates generally to corneal implants, and more particularly, to intracorneal inlays.


BACKGROUND INFORMATION

As is well known, abnormalities in the human eye can lead to vision impairment. Some typical abnormalities include variations in the shape of the eye, which can lead to myopia (near-sightedness), hyperopia (far-sightedness) and astigmatism as well as variations in the tissue present throughout the eye, such as a reduction in the elasticity of the lens, which can lead to presbyopia. A variety of technologies have been developed to try and address these abnormalities, including corneal implants.


Corneal implants can correct vision impairment by altering the shape of the cornea. Corneal implants can be classified as an onlay or an inlay. An onlay is an implant that is placed over the cornea such that the outer layer of the cornea, e.g., the epithelium, can grow over and encompass the implant. An inlay is an implant that is surgically implanted into the cornea beneath a portion of the corneal tissue by, for example, cutting a flap in the cornea and inserting the inlay beneath the flap. Both inlays and outlays can alter the refractive power of the cornea by changing the shape of the anterior cornea, by having a different index of refraction than the cornea, or both. Since the cornea is the strongest refracting optical element in the human ocular system, altering the cornea's anterior surface is a particularly useful method for correcting vision impairments caused by refractive errors. Inlays are also useful for correcting other visual impairments including presbyopia.


SUMMARY

Provided herein are small diameter inlays for correcting vision impairments by altering the shape of the anterior corneal surface.


In one embodiment, inlays having diameters smaller than the diameter of the pupil are provided for correcting presbyopia. To provide near vision, an inlay is implanted centrally in the cornea to induce an “effect” zone on the anterior corneal surface that is smaller than the optical zone of the cornea, wherein the “effect” zone is the area of the anterior corneal surface affected by the inlay. The implanted inlay increases the curvature of the anterior corneal surface within the “effect” zone, thereby increasing the diopter power of the cornea within the “effect” zone. Because the inlay is smaller than the diameter of the pupil, light rays from distance objects by-pass the inlay and refract using the region of the cornea peripheral to the “effect” zone to create an image of the distant objects on the retina.


The small diameter inlays may be used alone or in conjunction with other refractive procedures. In an embodiment, a small diameter inlay is used in conjunction with LASIK for correcting myopia or hyperopia. In this embodiment, a LASIK procedure is used to correct for distance refractive error and the small diameter inlay is used to provide near vision for presbyopic subjects.


In another embodiment, small diameter inlays are provided that induce effective optical zones on the anterior corneal surface that are much larger in diameter than the inlays. The increase in the effective optical zone allows an inlay to produce a much larger clinical effect on a patient's vision than the diameter of the inlay.


In one embodiment, the effective optical zone induced by the inlay is increased by increasing the draping effect of the inlay. The draping effect extends the area of the anterior corneal surface affected by the inlay, and thereby the effective optical zone induced by the inlay. In an embodiment, the draping effect is increased by increasing the finite edge thickness of the inlay for a given inlay diameter and center thickness.


In another embodiment, inlays having effective optical zones much larger than the inlay diameter are used to correct hyperopia. In this embodiment, the draping effect extends the area of the anterior corneal surface where the curvature is increased, thereby extending the effective optical zone of the inlay and providing increased diopter power over a wider diameter than the inlay diameter. This increase in the effective optical zone allows for the correction of hyperopia using smaller diameter inlays.


Other systems, methods, features and advantages of the invention will be or will become apparent to one with skill in the art upon examination of the following figures and detailed description. It is intended that all such additional systems, methods, features and advantages be included within this description, be within the scope of the invention, and be protected by the accompanying claims. It is also intended that the invention not be limited to the details of the example embodiments.





BRIEF DESCRIPTION OF THE FIGURES


FIG. 1 is a cross-sectional view of a cornea showing an intracorneal inlay implanted in the cornea according to an embodiment of the invention.



FIG. 2 is a diagram of an eye illustrating the use of a small diameter inlay to provide near vision according to an embodiment of the invention.



FIG. 3 is a cross-sectional view of a cornea showing an inlay implanted in the cornea and a change in the anterior corneal surface induced by the inlay including a drape region according to an embodiment of the invention.



FIG. 4 illustrates various possible shapes for the drape region.



FIG. 5 is a cross-sectional view of a cornea showing a thickness profile for providing a desired refractive correction according to an embodiment of the invention.



FIG. 6 is a 3D topographic difference map showing the change in the anterior corneal surface induced by an inlay according to an embodiment of the invention.



FIG. 7 shows an average radial elevation profile induced by an inlay according to an embodiment of the invention.



FIG. 8 shows a contour map of the refractive change induced by an inlay according to an embodiment of the invention.





DETAILED DESCRIPTION


FIG. 1 shows an example of an intracorneal inlay 10 implanted in a cornea 5. The inlay 10 may have a meniscus shape with an anterior surface 15 and a posterior surface 20. The inlay 10 is preferably implanted in the cornea at a depth of 50% or less of the cornea (approximately 250 μm or less), and is placed on the stromal bed 30 of the cornea created by a micro keratome. The inlay 10 may be implanted in the cornea 5 by cutting a flap 25 into the cornea, lifting the flap 25 to expose the cornea's interior, placing the inlay 10 on the exposed area of the cornea's interior, and repositioning the flap 25 over the inlay 10. The flap 25 may be cut using a laser, e.g., a femtosecond laser, a mechanical keratome or manually by an ophthalmic surgeon. When the flap 25 is cut into the cornea, a small section of corneal tissue is left intact to create a hinge for the flap 25 so that the flap 25 can be repositioned accurately over the inlay 20. After the flap 25 is repositioned over the inlay, the cornea heals around the flap 25 and seals the flap 25 back to the un-cut peripheral portion of the anterior corneal surface. Alternatively, a pocket or well having side walls or barrier structures may be cut into the cornea, and the inlay inserted between the side walls or barrier structures through a small opening or “port” in the cornea.


The inlay 10 changes the refractive power of the cornea by altering the shape of the anterior corneal surface. In FIG. 1, the pre-operative anterior corneal surface is represented by dashed line 35 and the post-operative anterior corneal surface induced by the underlying inlay 10 is represented by solid line 40.


The inlay may have properties similar to those of the cornea (e.g., index of refraction around 1.376, water content of 78%, etc.), and may be made of hydrogel or other clear bio-compatible material. To increase the optical power of the inlay, the inlay may be made of a material with a higher index of refraction than the cornea, e.g., >1.376. Materials that can be used for the inlay include, but are not limited to, Lidofilcon A, Poly-HEMA, poly sulfone, silicone hydrogel, and the like. The index of refraction may be in the range of 1.33 to 1.55.


Presbyopic Inlays


This section discusses the use of small intracorneal inlays having diameters that are small in comparison with the pupil for correcting presbyopia. In the preferred embodiment, a small inlay (e.g., 1 to 2 mm in diameter) is implanted centrally in the cornea to induce an “effect” zone on the anterior corneal surface that is smaller than the optical zone of the cornea for providing near vision. Here, “effect” zone is the area of the anterior corneal surface affected by the inlay. The implanted inlay increases the curvature of the anterior corneal surface within the “effect” zone, thereby increasing the diopter power of the cornea within the “effect” zone. Distance vision is provided by the region of the cornea peripheral to the “effect” zone.


Presbyopia is characterized by a decrease in the ability of the eye to increase its power to focus on nearby objects due to a loss of elasticity in the crystalline lens with age. Typically, a person suffering from Presbyopia requires reading glasses to provide near vision.



FIG. 2 shows an example of how a small inlay can provide near vision to a subject's eye while retaining some distance vision according to an embodiment of the invention. The eye 105 comprises the cornea 110, the pupil 115, the crystalline lens 120 and the retina 125. In this example, the small inlay (not shown) is implanted centrally in the cornea to create a small diameter “effect” zone 130. The small inlay has a smaller diameter than the pupil 115 so that the resulting “effect” zone 130 has a smaller diameter than the optical zone of the cornea. The “effect” zone 130 provides near vision by increasing the curvature of the anterior corneal surface, and therefore the diopter power within the “effect” zone 130. The region 135 of the cornea peripheral to the “effect” zone provides distance vision.


To increase the diopter power within the “effect” zone 130, the small inlay has a higher curvature than the pre-implant anterior corneal surface to increase the curvature of the anterior corneal surface within the “effect” zone 130. The inlay may further increase the diopter power within the “effect” zone 130 by having an index of refraction that is higher than the index of refraction of the cornea (ncornea=1.376). Thus, the increase in the diopter power within the “effect” zone 130 may be due to the change in the anterior corneal surface induced by the inlay or a combination of the change in the anterior cornea surface and the index of refraction of the inlay. For early presbyopes (e.g., about 45 to 55 years of age), at least 1 diopter is typically required for near vision. For complete presbyopes (e.g., about 60 years of age or older), between 2 and 3 diopters of additional power is required.


An advantage of the small intracorneal inlay is that when concentrating on nearby objects 140, the pupil naturally becomes smaller (e.g., near point miosis) making the inlay effect even more effective. Further increases in the inlay effect can be achieved by simply increasing the illumination of a nearby object (e.g., turning up a reading light).


Because the inlay is smaller than the diameter of the pupil 115, light rays 150 from distant objects 145 by-pass the inlay and refract using the region of the cornea peripheral to the “effect” zone to create an image of the distant objects on the retina 125, as shown in FIG. 2. This is particularly true with larger pupils. At night, when distance vision is most important, the pupil naturally becomes larger, thereby reducing the inlay effect and maximizing distance vision.


A subject's natural distance vision is in focus only if the subject is emmetropic (i.e., does not require glasses for distance vision). Many subjects are ammetropic, requiring either myopic or hyperopic refractive correction. Especially for myopes, distance vision correction can be provided by myopic Laser in Situ Keratomileusis (LASIK), Laser Epithelial Keratomileusis (LASEK), Photorefractive Keratectomy (PRK) or other similar corneal refractive procedures. After the distance corrective procedure is completed, the small inlay can be implanted in the cornea to provide near vision. Since LASIK requires the creation of a flap, the inlay may be inserted concurrently with the LASIK procedure. The inlay may also be inserted into the cornea after the LASIK procedure since the flap can be re-opened. Therefore, the small inlay may be used in conjunction with other refractive procedures, such as LASIK for correcting myopia or hyperopia.


A method for designing a small inlay to provide near vision will now be described. FIG. 3 shows a small inlay 210 implanted in the cornea 205 and the change in the shape of the anterior corneal surface 240 induced by the inlay 210. In FIG. 3, the pre-implant anterior corneal surface is represented by dashed line 235 and the post-implant anterior corneal surface induced by the inlay 210 is represented by solid line 240. The inlay 210 does not substantially affect the shape of the anterior corneal surface in the region of the cornea 210 peripheral to the “effect” zone so that distance vision is undisturbed in the peripheral 245. In the case where a distance corrective procedure is performed prior to implantation of the inlay, the pre-implant anterior corneal surface 235 is the anterior corneal surface after the distance corrective procedure but before implantation of the inlay.


The inlay 210 has a finite edge thickness 250. The edge thickness 250 can not be made zero due to the finite material properties of the inlay. The finite edge thickness 250 of the inlay produces a draping effect, as described further below. To minimize the draping effect, the edge thickness 250 of the inlay 210 can be made as small as possible, e.g., less than about 20 microns. In addition to a finite edge thickness 250, the inlay may have a tapered region (not shown) that tapers downward from the anterior surface 215 of the inlay to the edge 250 of the inlay. The tapered region may be 10-30 μm in length.


In FIG. 3, the portion of the anterior corneal surface directly above the inlay is altered by the physical shape of the inlay 210. Because of the finite edge thickness 250 of the inlay 210, the anterior corneal surface does not immediately return to its pre-implant shape for a diameter larger than the physical inlay 210. Eventually, the anterior corneal surface returns to the pre-implant corneal surface 235. Therefore, the draping effect produces a drape region 255 that extends the shape change of the anterior corneal surface induced by the inlay 210.



FIG. 4 illustrates a variety of possible draping shapes 355. FIG. 4 shows the radius (dI/2) of an inlay region 362 and the total radius (dz/2) of the shape change due to the draping effect. The possible draping shapes 355 are shown in dashed lines, and may depend on factors such as the edge thickness, the local mechanical properties of the flap material, the diameter of the inlay (dI), the mechanical properties of the inlay material, and other geometric factors. The precise shape of the drape can be approximated by invitro or invivo clinical experiments and/or by complex mechanical modeling using techniques such as finite element analysis.


It is useful to define the optical zone diameter (dz) corresponding to the size of the anterior corneal surface affected by the inlay 210, as shown in FIG. 3. For purposes of the design method, it is sufficient to assume that the relationship between the optical zone and the inlay diameter, given the other variables, can be determined by the methods outlined above.


A method for designing a small inlay to provide near vision according to an embodiment will now be given.


(1) The first step is to determine the maximum optical zone (dz) that is an acceptable tradeoff between the near vision improvement and the loss of distance vision. Considerations include the pupil size of the specific subject or a group of characteristic subjects (e.g., subjects within a particular age range) while reading nearby objects and the pupil size for distance viewing, especially at night. In an exemplary application, the inlay is placed in one eye to provide near vision and distance correction by other means is performed on the fellow eye. In this example, both eyes contribute to distance vision, with the non-inlay eye providing the sharpest distance vision. The eye with the inlay provides near vision.


(2) Given the empirically derived or theoretically derived relationship between the optical zone (dz) and the inlay diameter (dI), approximate the inlay diameter that achieves the optical zone.


(3) Design the inlay using the method outlined in detail below. This methods is similar to the design methods described in U.S. patent application Ser. No. 11/293,644, titled “Design Of Intracorneal Inlays,” filed on Dec. 1, 2005, the entirety of which is incorporated herein by reference.


(4) Finally, use optical ray-trace methods to assess the image quality of distance and near images with the inlay using the entire corneal surface (i.e., the corneal surface within the inlay diameter (dI), between the inlay diameter and the optical zone (dz), and the peripheral to the optical zone). Make small adjustments to the inlay design to optimize the distance and near image quality based on the inlay design method outlined below and the predicted drape shape given by the methods described above.


The design method of step three will now be given.



FIGS. 3 and 4 show two regions affected by the inlay design: a “central region” 260 defined by the inlay diameter (dI), and a “drape region” 255 falling between the inlay diameter and the optical zone (dz). The design method described below is used to design inlays to produce desired shapes of the anterior corneal surface in the central region to correct presbyopia. This design method assumes that the inlay material has the same index of refraction as the cornea.


A first step in the design of an inlay in the central region is determining a thickness profile that the inlay must induce on the anterior corneal surface to produce a desired anterior corneal curvature. The desired ADD power needed to provide near focus dictates the desired anterior corneal curvature in the central region (FIG. 4).


A first step in determining the thickness profile of the inlay is to determine an anterior radius of curvature, r′a, that provides the desired refractive change, ΔRx=Rxdist−ADD, where ADD is the desired ADD power prescribed for near vision and Rxdist is the distance refraction prior to inlay implant. Rxdist is approximately zero diopters for emmetropic individuals, or is equal to the achieved or targeted post-operative distance refraction after a surgical procedure to correct the distance ammetropia. The equivalent change in the cornea's refractive power, ΔKequiv, at the anterior surface is given by:










Δ






K
equiv


=


1


1
Rxdist

-
V


-

1


1
ADD

-
V







Equation





1








where V is a spectacle vertex distance, e.g., 0.012 meters, from a spectacle to the cornea's anterior surface. The spectacle vertex distance, V, takes into account that measurements of the cornea's refractive power are typically taken with a spectacle located a distance from the cornea's anterior surface, and translates these power measurements to the equivalent power at cornea's anterior surface.


The pre-implant refractive power at the anterior corneal surface may be approximated by Kavg−Kpost, where Kavg is the average corneal refractive power within approximately the optical zone created by the inlay and Kpost is a posterior corneal refractive power. The desired radius of curvature, r′a, of the anterior surface may be given by:










r
a


=


(

1.346
-
1

)


(

Kavg
-
Kpost
+

Δ






K
equiv



)






Equation





2








For purposes of design and analysis, Kpost may be approximated as −6 diopters. The pre-implant radius of curvature, rpreimplant, may be approximated by:

rpreimplant=(1.376−1)/(Kavg−Kpost)  Equation 3

The two radius of curvatures need not originate from the same origin.



FIG. 5 shows a cross-sectional view of a thickness profile 510 specified by a difference between the desired anterior corneal surface 540 and the pre-implant anterior corneal surface 535. In FIG. 5, arrows 550 pointing from the pre-implant anterior surface 535 to the desired anterior surface 540 represent the axial thickness, L(r), of the thickness profile 510 at different positions along an r axis that is substantially perpendicular to an optical z axis. The double arrow 560 represents a center thickness, Lc, of the thickness profile. In this embodiment, the thickness profile 510 is rotationally symmetric about the z axis. Thus, the entire thickness profile may be defined by rotating the cross-sectional view shown in FIG. 5 about the z axis.


The thickness L(r) of the thickness profile may be given by:

L(r)=Lc+Zpreimplant(r;rpreimplant)−Zanew(r;r′a) and
Lc=Zanew(dI/2)−Zpreimplant(dI/2)  Equation 4

where Lc is the center thickness of the thickness profile, Zimplant(r) is the pre-operative anterior corneal surface as a function of r, Zanew (r) is the desired anterior corneal surface as a function of r, and dI is the diameter of the inlay. In the example above, the anterior surfaces Zanew and Zpreimplant were assumed to be spherical. This need not be the case. The anterior surfaces may also be aspheric. More generally, the desired anterior surface Zanew may be a function of desired ADD and also more complex design parameters, e.g., an aspheric surface for higher-order aberration correction. Also, the pre-implant anterior surface Zpreimplant is generally aspheric. For designs requiring aspheric surfaces, the surface function Z(r) may be given by the general aspheric form:










Z


(
r
)


=




r
2


r
c



1
+


1
-


(

1
+
k

)




(

r

r
c


)

2






+


a
4



r
4


+


a
6



r
6







Equation





5








where:

    • rc is the radius of curvature
    • k is a conic constant
    • a4 and a6 are higher order aspheric constants


      For a spherical surface, k=0, a4=0, and a6=0. The human cornea may be approximated by k=−0.16, a4=0 and a6=0. The radius of curvature, rc, may be specified by the ADD power for correction of presbyopia, and the other parameters may specify corrections for higher-order aberrations.


The above expressions for the thickness profile are intended to be exemplary only. Other mathematical expressions or parameters may be used to describe similar or other thickness profiles. Therefore, the invention is not limited to particular mathematical expressions or parameters for describing the thickness profile.


After the required thickness profile L(r) is determined, the inlay is dimensioned to have substantially the same thickness profile. The profiles should have the same thickness to within about one micron, which would cause a diopter difference of about one eight of a diopter if the center thickness differs by one micron. An eight of a diopter is half the accuracy with which ophthalmic refractive errors are manually recorded. Next, the thickness profile of the inlay is increased by the finite edge thickness (hedge) by the manufacturing process. This finite edge thickness is one factor inducing the drape as illustrated in FIG. 4. When implanted in the cornea, the thickness profile of the inlay is substantially transferred to the anterior corneal surface through the intervening flap, thereby producing the desired post-implant anterior corneal surface in the central region. The draping effect causes the change in the anterior corneal surface thickness to extend beyond the central region. This draping effect can be minimized, e.g., by reducing the finite edge thickness of the inlay as much as possible.


The design method above assumed that the index of refractive of the inlay is the same as the cornea, in which case changes in refractive power of the cornea is due solely to the change in the anterior corneal surface induced by the inlay. An inlay with intrinsic power (e.g., a higher index of refraction than the cornea) may also be used, in which changes in the refractive power is provided by a combination of the physical inlay shape and the intrinsic power (i.e., index of refraction) of the inlay. Design methods for inlays with intrinsic power is described in application Ser. No. 11/381,056, titled “Design Of Inlays With Intrinsic Diopter Power,” filed on May 1, the entirety of which is incorporated herein by reference.


Inlays With Increased Effective Optical Zones


For some applications, it is desirable for an inlay to induce an effective optical zone on the anterior corneal surface that is much larger than the inlay diameter. The increase in the effective optical zone allows the inlay to produce a much larger clinical effect on the patient's vision than the actual inlay diameter. In one example, a 1.5 mm-2 mm range diameter inlay has an increased effective optical zone of 4 mm-5 mm, in which the optical effect of the inlay is 2× to 3× greater than its diameter. The increased effective optical zone can also be achieved with inlay diameters outside the above range. For example, the diameter of the inlay may go down to 1 mm or less for some designs, while achieving the desired optical effect.


The increase in the effective optical zone (i.e., “effect” zone) of the inlay can be achieved by increasing the draping effect of the inlay. Increasing the draping effect extends the drape region, and therefore the effective optical zone (i.e., the area of the anterior corneal surface affected by the inlay). The draping effect may be increased, e.g., by increasing the finite edge thickness of the inlay so that the anterior corneal surface returns to its pre-implant surface at a larger radius.


Small diameter inlays inducing effective optical zones much larger than the inlay diameter may be used to correct hyperopia. For example, an inlay with a diameter of 2 mm can provide increased diopter power over an effective optical zone having a diameter of 4 mm. The curvature of the anterior corneal surface in the drape region is greater than the pre-implant anterior corneal surface. Therefore, the draping effect extends the area of the anterior corneal surface where the curvature is increased, thereby extending the effective optical zone of the inlay and providing increased diopter power over a wider diameter than the inlay diameter. This increase in the effective optical zone allows for the correction of hyperopia using smaller diameter inlays.


An inlay with increased effective optical zone may also be used to correct various vision impairments including presbyopia, hyperopia, myopia, and higher order aberrations. In the case of presbyopia, a sufficient “effect” zone may be achieved with an even smaller diameter inlay. For example, a 1 mm diameter inlay may be used to produce a 2 mm diameter “effect” zone.


Clinical data will now be presented in which the effective optical zone induced by an inlay is larger than the inlay diameter. In general, topographic instruments can be used to measure the change in the anterior surface elevation induced by an inlay, calculate the change in the anterior surface curvature and deduce the change in the diopter power. FIG. 6 shows an example of a 3D topographic difference map showing the change in the anterior corneal surface for a subject (subject 1) between a preoperative examination and a one week postoperative examination. In this example, an intracorneal inlay was implanted in subject 1 having a diameter of 2 mm, a center thickness of approximately 36 microns, and an edge thickness of approximately 30 microns. The inlay was placed under a corneal flap created using a laser keratome (by Intralase, Inc.) at a depth of approximately 110 microns. A Scheimpflug topographer (“Pentacam” by Oculus, Inc.) was used to measure the surfaces. From FIG. 6, it is clear that the implanted inlay steepened the anterior corneal surface.



FIG. 7 shows the average radial elevation profile calculated from data in FIG. 6. Average radial profiles for two additional subjects (subjects 2 and 3) who received the same inlay design are also shown. Note that the central anterior surface elevation change was less than the center thickness of the inlay. This reflects biomechanical interactions between the inlay material, stromal bed on which it rests and the overlying keratometric flap. However, in all cases the inlay increased the anterior surface elevation beyond the physical diameter of the inlay. FIG. 7 suggests that the effective optical zone induced by the inlay was approximately twice the inlay diameter for this particular design. Inlays with different diameters, center thicknesses and thickness profiles may have different “effect” zone sizes.



FIG. 8 shows a contour map of the refractive change induced by the intracorneal inlay. This is calculated from the elevation differences by calculating the sagittal curvature map and converting to diopter power using:

Diopter power=(nc−1)/sagittal curvature

where nc is the index of refraction of the cornea. Again, the effective optical zone of the inlay was greater than the diameter of the inlay.


In the foregoing specification, the invention has been described with reference to specific embodiments thereof. It will, however, be evident that various modifications and changes may be made thereto without departing from the broader spirit and scope of the invention. As another example, each feature of one embodiment can be mixed and matched with other features shown in other embodiments. As yet another example, the order of steps of method embodiments may be changed. Features and processes known to those of ordinary skill may similarly be incorporated as desired. Additionally and obviously, features may be added or subtracted as desired. Accordingly, the invention is not to be restricted except in light of the attached claims and their equivalents.

Claims
  • 1. A method for treating presbyopia using an intracorneal inlay, comprising: altering the shape of the anterior surface of a cornea to correct near vision by implanting the inlay in the cornea, wherein the inlay has a diameter of approximately 2.5 mm or less, and distance vision is provided by a region of the cornea peripheral to an area of the anterior surface affected by the inlay.
  • 2. The method of claim 1, wherein the inlay has an index of refraction substantially equal to the index of refraction of the cornea.
  • 3. The method of claim 1, wherein the inlay has an index of refraction higher than the index of refraction of the cornea.
  • 4. The method of claim 1, wherein the inlay is implanted at a depth of 25% or less of the cornea.
  • 5. The method of claim 1, wherein a curvature of an anterior surface of the inlay is higher than the curvature of the anterior surface of the cornea.
  • 6. The method of claim 1, further comprising: prior to implantation of the inlay, performing a corrective procedure on the cornea to correct distance vision.
  • 7. The method of claim 6, wherein the corrective procedure to correct distance vision comprises a LASIK procedure.
  • 8. The method of claim 7, further comprising: cutting a flap in the cornea during the LASIK procedure; andafter the LASIK procedure, reopening the flap and implanting the inlay beneath the flap.
  • 9. The method of claim 1, further comprising performing a corrective procedure to correct distance vision concurrently with implantation of the inlay.
  • 10. The method of claim 9, wherein the corrective procedure to correct distance vision comprises a LASIK procedure.
  • 11. The method of claim 10, further comprising: cutting a flap in the cornea during the LASIK procedure; andimplanting the inlay beneath the flap.
  • 12. The method of claim 1, wherein the inlay has a diameter of approximately 2 mm or less.
  • 13. The method of claim 1, wherein the inlay has a diameter of approximately 1.5 mm or less.
  • 14. The method of claim 1, further comprising: cutting a flap in the cornea;lifting the flap to expose an interior of the cornea;placing the inlay in the interior of the cornea; andrepositioning the flap over the inlay.
  • 15. The method of claim 1, further comprising: cutting a pocket in an interior of the cornea; andplacing the inlay in the pocket.
  • 16. A method for correcting vision impairment, comprising: implanting an inlay having a diameter less than 4 mm in a cornea of an eye, wherein the inlay produces an effective optical zone on the anterior surface of the cornea greater than the diameter of the inlay, wherein the diameter of the inlay is less than the diameter of a dilated or undilated pupil of the eye, and wherein the effective optical zone is smaller than the pupil of the eye.
  • 17. The method of claim 16, wherein the diameter of the effective optical zone is at least 1.5 times greater than the diameter of the inlay.
  • 18. The method of claim 16, wherein the diameter of the effective optical zone is at least two times greater than the diameter of the inlay.
  • 19. The method of claim 16, wherein the inlay increases the curvature of the anterior surface of the cornea, and an area of increased curvature has a diameter greater than the diameter of the inlay.
  • 20. The method of claim 19, wherein the area of increased curvature has a diameter at least 1.5 times greater than the diameter of the inlay.
  • 21. The method of claim 19, wherein the area of increased curvature has a diameter at least 2 times greater than the diameter of the inlay.
  • 22. The method of claim 16, wherein the diameter of the inlay is less than 3 mm.
  • 23. The method of claim 16, wherein the diameter of the inlay is in the range of 1.5 mm to 2 mm.
  • 24. The method of claim 16, wherein the diameter of the inlay is less than 1.5 mm.
  • 25. The method of claim 16, wherein the diameter of the inlay is less than 4 mm and the effective optical zone is 8 mm or less.
  • 26. The method of claim 16, wherein the diameter of the inlay is less than 3 mm and the effective optical zone is in the range of about 6 mm to 8 mm.
  • 27. The method of claim 16, wherein the diameter of the inlay in the range of 1.5 mm to 2 mm and the effective optical zone is in the range of about 4 mm to 5 mm.
  • 28. The method of claim 16, wherein the diameter of the inlay is less than 1.5 mm and the effective optical zone is in the range of about 2 mm to 4 mm.
  • 29. The method of claim 16, wherein the diameter of the inlay is less than 1 mm.
  • 30. The method of claim 16, wherein the diameter of the inlay is less than 1 mm and the effective optical zone is in the range of about 2 mm to 4 mm.
  • 31. The method of claim 16, wherein the center thickness of the inlay is less than 50 μm.
  • 32. The method of claim 16, wherein the inlay is implanted in the cornea at a depth of 170 μm.
  • 33. The method of claim 16, wherein the refractive index of the inlay is in the range of about 1.33 to 1.55.
  • 34. The method of claim 16 wherein the effective optical zone comprises a central region to correct near vision, and wherein distance vision is provided in a region of the cornea peripheral to the effective optical zone.
  • 35. A method for providing near and distance vision in an eye using an intracorneal inlay, comprising: altering the shape of a region of the anterior surface of a cornea of the eye to provide near vision by implanting an inlay in the cornea, wherein the inlay has a diameter less than 4 mm and less than the diameter of a dilated or undilated pupil of the eye, wherein a region of the anterior surface of the cornea affected by the inlay is larger than the diameter of the inlay; andproviding distance vision in a region of the cornea peripheral to the region of the anterior surface of the cornea affected by the inlay.
  • 36. The method of claim 35 wherein the inlay has an index of refraction that is substantially the same as the index of refraction of the cornea.
  • 37. The method of claim 35 wherein the inlay has a diameter less than about 3 mm.
  • 38. The method of claim 35 wherein the inlay has a diameter between about 1.5 mm and about 2 mm.
RELATED APPLICATION

This application claims the benefit of U.S. Provisional Application Ser. No. 60/776,458, filed on Feb. 24, 2006.

US Referenced Citations (345)
Number Name Date Kind
2714721 Stone, Jr. Aug 1955 A
3168100 Rich Feb 1965 A
3343657 Speshyock Sep 1967 A
3379200 Pennell Apr 1968 A
3482906 Volk Dec 1969 A
3743337 Crary Jul 1973 A
3770113 Thomas Nov 1973 A
3879076 Barnett Apr 1975 A
3950315 Cleaver Apr 1976 A
3996627 Deeg et al. Dec 1976 A
4030480 Meyer Jun 1977 A
4037604 Newkirk Jul 1977 A
4039827 Zdrok et al. Aug 1977 A
4065816 Sawyer Jan 1978 A
4071272 Drdlik Jan 1978 A
4136406 Norris Jan 1979 A
4157718 Baehr Jun 1979 A
4184491 McGannon Jan 1980 A
4194814 Fischer et al. Mar 1980 A
4238524 LaLiberte et al. Dec 1980 A
4257521 Poler Mar 1981 A
4268133 Fischer et al. May 1981 A
4326306 Poler Apr 1982 A
4357940 Muller Nov 1982 A
4392569 Shoup Jul 1983 A
4418991 Breger Dec 1983 A
4423809 Mazzocco Jan 1984 A
4428746 Mendez Jan 1984 A
4452235 Reynolds Jun 1984 A
4466705 Michelson Aug 1984 A
4490860 Rainin Jan 1985 A
4504982 Burk Mar 1985 A
4521210 Wong Jun 1985 A
4525044 Bauman Jun 1985 A
4545478 Waldman Oct 1985 A
4554115 Neefe Nov 1985 A
4554918 White Nov 1985 A
4565198 Koeniger Jan 1986 A
4580882 Nuchman et al. Apr 1986 A
4586929 Binder May 1986 A
4604087 Joseph Aug 1986 A
4607617 Choyce Aug 1986 A
4616910 Klein Oct 1986 A
4618227 Bayshore Oct 1986 A
4619256 Horn Oct 1986 A
4624664 Peluso et al. Nov 1986 A
4624669 Grendahl Nov 1986 A
4640595 Volk Feb 1987 A
4646720 Peyman et al. Mar 1987 A
4655774 Choyce Apr 1987 A
4662370 Hoffmann et al. May 1987 A
4663358 Hyon et al. May 1987 A
4671276 Reynolds Jun 1987 A
4676792 Praeger Jun 1987 A
4697697 Graham et al. Oct 1987 A
4702244 Mazzocco Oct 1987 A
4709697 Muller Dec 1987 A
4726367 Shoemaker Feb 1988 A
4750901 Molteno Jun 1988 A
4762496 Maloney et al. Aug 1988 A
4766895 Reynolds Aug 1988 A
4769033 Nordan Sep 1988 A
4772283 White Sep 1988 A
4778462 Grendahl Oct 1988 A
4798609 Grendahl Jan 1989 A
4806382 Goldberg et al. Feb 1989 A
4836201 Patton et al. Jun 1989 A
4840175 Peyman Jun 1989 A
4842599 Bronstein Jun 1989 A
4844242 Chen et al. Jul 1989 A
4851003 Lindstrom Jul 1989 A
4860885 Kaufman et al. Aug 1989 A
4886488 White Dec 1989 A
4888016 Langerman Dec 1989 A
4897981 Beck Feb 1990 A
4911715 Kelman Mar 1990 A
4919130 Stoy et al. Apr 1990 A
4923467 Thompson May 1990 A
4934363 Smith et al. Jun 1990 A
4936825 Ungerleider Jun 1990 A
4946436 Smith Aug 1990 A
4955903 Sulc et al. Sep 1990 A
4968296 Ritch et al. Nov 1990 A
4971732 Wichterle Nov 1990 A
4976719 Siepser Dec 1990 A
5019084 Aysta et al. May 1991 A
5019098 Mercier May 1991 A
5022414 Muller Jun 1991 A
5030230 White Jul 1991 A
5041081 Odrich Aug 1991 A
5063942 Kilmer et al. Nov 1991 A
5071276 Nielsen et al. Dec 1991 A
5073163 Lippman Dec 1991 A
5092837 Ritch et al. Mar 1992 A
5098444 Feaster Mar 1992 A
5108428 Capecchi et al. Apr 1992 A
5112350 Civerchia et al. May 1992 A
5123905 Kelman Jun 1992 A
5123921 Werblin et al. Jun 1992 A
5139518 White Aug 1992 A
5171213 Price, Jr. Dec 1992 A
5173723 Volk Dec 1992 A
5178604 Baerveldt et al. Jan 1993 A
5180362 Worst Jan 1993 A
5181053 Brown Jan 1993 A
5188125 Kilmer et al. Feb 1993 A
5190552 Kelman Mar 1993 A
5192317 Kalb Mar 1993 A
5196026 Barrett et al. Mar 1993 A
5211660 Grasso May 1993 A
5225858 Portney Jul 1993 A
5229797 Futhey et al. Jul 1993 A
5244799 Anderson Sep 1993 A
5258042 Mehta Nov 1993 A
5270744 Portney Dec 1993 A
5273750 Homiger et al. Dec 1993 A
5282851 Jacob-LaBarre Feb 1994 A
5300020 L'Esperance, Jr. Apr 1994 A
5300116 Chirila et al. Apr 1994 A
5312413 Eaton et al. May 1994 A
5318044 Kilmer et al. Jun 1994 A
5318046 Rozakis Jun 1994 A
5318047 Davenport et al. Jun 1994 A
5336261 Barrett et al. Aug 1994 A
5338291 Speckman et al. Aug 1994 A
5344448 Schneider et al. Sep 1994 A
5346464 Camras Sep 1994 A
5370607 Memmen Dec 1994 A
5372577 Ungerleider Dec 1994 A
5385582 Ommaya Jan 1995 A
5391201 Barrett et al. Feb 1995 A
5397300 Baerveldt et al. Mar 1995 A
5405384 Silvestrini Apr 1995 A
5428412 Stoyan Jun 1995 A
5433701 Rubinstein Jul 1995 A
5454796 Krupin Oct 1995 A
5458819 Chirila et al. Oct 1995 A
5467149 Morrison et al. Nov 1995 A
5474562 Orchowski et al. Dec 1995 A
5476445 Baerveldt et al. Dec 1995 A
5489301 Barber Feb 1996 A
5493350 Seidner Feb 1996 A
5502518 Lieberman Mar 1996 A
5512220 Roffman et al. Apr 1996 A
5520631 Nordquist et al. May 1996 A
5521656 Portney May 1996 A
5530491 Baude et al. Jun 1996 A
5533997 Ruiz Jul 1996 A
5570142 Lieberman Oct 1996 A
5591185 Kilmer et al. Jan 1997 A
5598234 Blum et al. Jan 1997 A
5616148 Eagles et al. Apr 1997 A
5620450 Eagles et al. Apr 1997 A
5628794 Lindstrom May 1997 A
5630810 Machat May 1997 A
5634943 Villain et al. Jun 1997 A
5643276 Zaleski Jul 1997 A
5657108 Portney Aug 1997 A
5682223 Menezes et al. Oct 1997 A
5684560 Roffman et al. Nov 1997 A
5715031 Roffman et al. Feb 1998 A
5716633 Civerchia Feb 1998 A
5722948 Gross Mar 1998 A
5722971 Peyman Mar 1998 A
5728155 Anello et al. Mar 1998 A
5752928 de Roulhac et al. May 1998 A
5755785 Rowsey et al. May 1998 A
5766181 Chambers et al. Jun 1998 A
5772667 Blake Jun 1998 A
5785674 Mateen Jul 1998 A
5800442 Wolf et al. Sep 1998 A
5800529 Brauker et al. Sep 1998 A
5805260 Roffman et al. Sep 1998 A
5810833 Brady et al. Sep 1998 A
5817115 Nigam Oct 1998 A
5824086 Silvestrini Oct 1998 A
5847802 Menezes et al. Dec 1998 A
5855604 Lee Jan 1999 A
5860984 Chambers et al. Jan 1999 A
5872613 Blum et al. Feb 1999 A
5873889 Chin Feb 1999 A
5876439 Lee Mar 1999 A
5888243 Silverstrini Mar 1999 A
5913898 Feingold Jun 1999 A
5919185 Peyman Jul 1999 A
5928245 Wolf et al. Jul 1999 A
5929968 Cotie et al. Jul 1999 A
5929969 Roffman Jul 1999 A
5941583 Raimondi Aug 1999 A
5944752 Silvestrini Aug 1999 A
5945498 Hopken et al. Aug 1999 A
5964748 Peyman Oct 1999 A
5964776 Peyman Oct 1999 A
5968065 Chin Oct 1999 A
5976150 Copeland Nov 1999 A
5976168 Chin Nov 1999 A
5980549 Chin Nov 1999 A
6007510 Nigam Dec 1999 A
6010510 Brown et al. Jan 2000 A
6024448 Wu et al. Feb 2000 A
6033395 Peyman Mar 2000 A
6036714 Chin Mar 2000 A
6050999 Paraschac et al. Apr 2000 A
6055990 Thompson May 2000 A
6066170 Lee May 2000 A
6068642 Johnson et al. May 2000 A
6079826 Appleton et al. Jun 2000 A
6083231 Van Noy et al. Jul 2000 A
6086202 Chateau et al. Jul 2000 A
6090141 Lindstrom Jul 2000 A
6102946 Nigam Aug 2000 A
6110166 Juhasz et al. Aug 2000 A
6120148 Fiala et al. Sep 2000 A
6125294 Scholl et al. Sep 2000 A
6129733 Brady et al. Oct 2000 A
6139560 Kremer Oct 2000 A
6142969 Nigam Nov 2000 A
6143001 Brown et al. Nov 2000 A
6159241 Lee et al. Dec 2000 A
6171324 Cote et al. Jan 2001 B1
6175754 Scholl et al. Jan 2001 B1
RE37071 Gabrielian et al. Feb 2001 E
6183513 Guenthner et al. Feb 2001 B1
6197019 Peyman Mar 2001 B1
6197057 Peyman et al. Mar 2001 B1
6197058 Portney Mar 2001 B1
6203538 Peyman Mar 2001 B1
6203549 Waldock Mar 2001 B1
6203557 Chin Mar 2001 B1
6206919 Lee Mar 2001 B1
6210005 Portney Apr 2001 B1
6214015 Reich et al. Apr 2001 B1
6214044 Silverstrini Apr 2001 B1
6217571 Peyman Apr 2001 B1
6221067 Peyman Apr 2001 B1
6228114 Lee May 2001 B1
6248111 Glick et al. Jun 2001 B1
6250757 Roffman et al. Jun 2001 B1
6251114 Farmer et al. Jun 2001 B1
6264648 Peyman Jul 2001 B1
6264670 Chin Jul 2001 B1
6264692 Woffinden et al. Jul 2001 B1
6267768 Deacon et al. Jul 2001 B1
6271281 Liao et al. Aug 2001 B1
6277137 Chin Aug 2001 B1
6280449 Blake Aug 2001 B1
6280470 Peyman Aug 2001 B1
6283595 Breger Sep 2001 B1
6302877 Ruiz Oct 2001 B1
6325509 Hodur et al. Dec 2001 B1
6325792 Swinger et al. Dec 2001 B1
6361560 Nigam Mar 2002 B1
6364483 Grossinger et al. Apr 2002 B1
6371960 Heyman et al. Apr 2002 B2
6391230 Sarbadhikari May 2002 B1
6398277 McDonald Jun 2002 B1
6398789 Capetan Jun 2002 B1
6428572 Nagai Aug 2002 B2
6435681 Portney Aug 2002 B2
6436092 Peyman Aug 2002 B1
6447519 Brady et al. Sep 2002 B1
6447520 Ott et al. Sep 2002 B1
6458141 Peyman Oct 2002 B1
6461384 Hoffmann et al. Oct 2002 B1
6471708 Green Oct 2002 B2
6474814 Griffin Nov 2002 B1
6506200 Chin Jan 2003 B1
6511178 Roffman et al. Jan 2003 B1
6527389 Portney Mar 2003 B2
6537283 Van Noy Mar 2003 B2
6543610 Nigam Apr 2003 B1
6544286 Perez Apr 2003 B1
6551307 Peyman Apr 2003 B2
6554424 Miller et al. Apr 2003 B1
6554425 Roffman et al. Apr 2003 B1
6557998 Portney May 2003 B2
6581993 Nigam Jun 2003 B2
6582076 Roffman et al. Jun 2003 B1
6589203 Mitrev Jul 2003 B1
6589280 Koziol Jul 2003 B1
6592591 Polla et al. Jul 2003 B2
6596000 Chan et al. Jul 2003 B2
6605093 Blake Aug 2003 B1
6607537 Binder Aug 2003 B1
6607556 Nigam Aug 2003 B1
6623522 Nigam Sep 2003 B2
6626941 Nigam Sep 2003 B2
6629979 Feingold et al. Oct 2003 B1
6632244 Nigam Oct 2003 B1
6645246 Weinschenk, III et al. Nov 2003 B1
6648877 Juhasz et al. Nov 2003 B1
6657029 Vanderbilt Dec 2003 B2
6666887 Callahan et al. Dec 2003 B1
6673112 Nigam Jan 2004 B2
6709103 Roffman et al. Mar 2004 B1
6712848 Wolf et al. Mar 2004 B1
6723104 Ott Apr 2004 B2
6733507 McNicholas et al. May 2004 B2
6733526 Paul et al. May 2004 B2
6808262 Chapoy et al. Oct 2004 B2
6824178 Nigam Nov 2004 B2
6855163 Peyman Feb 2005 B2
6875232 Nigam Apr 2005 B2
6879402 Küchel Apr 2005 B2
6881197 Nigam Apr 2005 B1
6893461 Nigam May 2005 B2
6949093 Peyman Sep 2005 B1
7128351 Nigam Oct 2006 B2
20010027314 Peyman Oct 2001 A1
20010051826 Bogaert et al. Dec 2001 A1
20020055753 Silvestrini May 2002 A1
20020101563 Miyamura et al. Aug 2002 A1
20020103538 Hughes et al. Aug 2002 A1
20030014042 Juhasz et al. Jan 2003 A1
20030033010 Hicks et al. Feb 2003 A1
20030069637 Lynch et al. Apr 2003 A1
20030078487 Jeffries et al. Apr 2003 A1
20030229303 Haffner et al. Dec 2003 A1
20040019379 Glick et al. Jan 2004 A1
20040034413 Christensen Feb 2004 A1
20040049267 Nigam Mar 2004 A1
20040054408 Glick et al. Mar 2004 A1
20040073303 Schanzlin Apr 2004 A1
20050080484 Marmo et al. Apr 2005 A1
20050080485 Nigam Apr 2005 A1
20050113844 Nigam May 2005 A1
20050119738 Nigam Jun 2005 A1
20050143717 Peyman Jun 2005 A1
20050178394 Slade Aug 2005 A1
20050182350 Nigam Aug 2005 A1
20050203494 Holliday Sep 2005 A1
20050246015 Miller Nov 2005 A1
20050246016 Miller et al. Nov 2005 A1
20060020267 Marmo Jan 2006 A1
20060116762 Hong et al. Jun 2006 A1
20060142780 Pynson et al. Jun 2006 A1
20060142781 Pynson et al. Jun 2006 A1
20060212041 Nigam Sep 2006 A1
20060235430 Le et al. Oct 2006 A1
20070027538 Aharoni et al. Feb 2007 A1
20070129797 Lang et al. Jun 2007 A1
20070255401 Lang Nov 2007 A1
20070280994 Cunanan Dec 2007 A1
20080262610 Lang et al. Oct 2008 A1
20090198325 Holliday et al. Aug 2009 A1
Foreign Referenced Citations (23)
Number Date Country
3208729 Sep 1983 DE
0308077 Mar 1989 EP
0420549 Apr 1991 EP
01-195853 Aug 1989 JP
02-211119 Aug 1990 JP
5502811 May 1993 JP
08-501009 Feb 1996 JP
9-504706 May 1997 JP
2000506056 May 2000 JP
03-508135 Mar 2003 JP
WO 9626690 Sep 1996 WO
WO 9808549 Mar 1998 WO
WO 9848715 Nov 1998 WO
WO 9917691 Apr 1999 WO
WO 9921513 May 1999 WO
WO 9930645 Jun 1999 WO
WO 0038594 Jul 2000 WO
WO 03041616 May 2003 WO
WO 03061518 Jul 2003 WO
WO 03101341 Dec 2003 WO
WO 2006029316 Apr 2006 WO
WO 2006060363 Jun 2006 WO
WO 2007101016 Sep 2007 WO
Related Publications (1)
Number Date Country
20070203577 A1 Aug 2007 US
Provisional Applications (1)
Number Date Country
60776458 Feb 2006 US